TriSalus Life Sciences, Inc. financial data

Symbol
TLSI, TLSIW on Nasdaq
Location
Westminster, CO
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 278% % 65%
Quick Ratio 36% % 43%
Debt-to-equity -223% % -16%
Return On Equity 149% % -27%
Return On Assets -121% % 44%
Operating Margin -78% % 51%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49,964,311 shares 64%
Common Stock, Shares, Outstanding 49,891,299 shares 64%
Common Stock, Value, Issued $4,000 USD 33%
Weighted Average Number of Shares Outstanding, Basic 43,057,632 shares 62%
Weighted Average Number of Shares Outstanding, Diluted 43,057,632 shares 62%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $40,207,000 USD 50%
Research and Development Expense $15,354,000 USD -32%
Selling and Marketing Expense $27,746,000 USD 14%
General and Administrative Expense $21,943,000 USD 13%
Operating Income (Loss) $31,255,000 USD 27%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $39,576,000 USD 29%
Income Tax Expense (Benefit) $6,000 USD -25%
Net Income (Loss) Attributable to Parent $39,582,000 USD 29%
Earnings Per Share, Basic -2 USD/shares -107%
Earnings Per Share, Diluted -2 USD/shares -107%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $22,687,000 USD 101%
Accounts Receivable, after Allowance for Credit Loss, Current $5,000,000 USD 1.8%
Inventory, Net $3,276,000 USD -18%
Assets, Current $33,328,000 USD 40%
Operating Lease, Right-of-Use Asset $890,000 USD -38%
Other Assets, Noncurrent $419,000 USD -1.2%
Assets $36,463,000 USD 33%
Accrued Liabilities, Current $6,773,000 USD -14%
Liabilities, Current $10,910,000 USD 10%
Liabilities $63,188,000 USD 32%
Retained Earnings (Accumulated Deficit) $320,970,000 USD -19%
Stockholders' Equity Attributable to Parent $26,725,000 USD -31%
Liabilities and Equity $36,463,000 USD 33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,499,000 USD 59%
Net Cash Provided by (Used in) Financing Activities $9,688,000 USD 210%
Net Cash Provided by (Used in) Investing Activities $714,000 USD -982%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 49,891,299 shares 64%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,475,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $23,037,000 USD 98%
Interest Paid, Excluding Capitalized Interest, Operating Activities $709,000 USD 23533%
Payments to Acquire Property, Plant, and Equipment $754,000 USD 1042%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $294,241,000 USD 18%
Preferred Stock, Shares Outstanding 0 shares -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%